Fingerprint
Dive into the research topics of 'PEG-IFN-α-2b therapy in BCR-ABL-negative myeloproliferative disorders: Final result of a phase 2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
PEG-IFN-α-2b therapy in BCR-ABL-negative myeloproliferative disorders: Final result of a phase 2 study
Elias Jabbour, Hagop Kantarjian, Jorge Cortes, Deborah Thomas, Guillermo Garcia-Manero, Alessandra Ferrajoli, Stefan Faderl, Mary Ann Richie, Miloslav Beran, Francis Giles, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
106
Scopus
citations